Sökning: onr:"swepub:oai:lup.lub.lu.se:c39bfcaa-dc03-43da-b411-12af02946532" >
Lipid nanoparticles...
Lipid nanoparticles for local delivery of mRNA to the respiratory tract : Effect of PEG-lipid content and administration route
-
- Ongun, Melike (författare)
- University of Copenhagen
-
- Lokras, Abhijeet Girish (författare)
- University of Copenhagen
-
- Baghel, Saahil (författare)
- University of Copenhagen
-
visa fler...
-
- Shi, Zhenning (författare)
- University of Copenhagen
-
- Schmidt, Signe Tandrup (författare)
- Danish Serum Institute, Copenhagen
-
- Franzyk, Henrik (författare)
- University of Copenhagen
-
- Rades, Thomas (författare)
- University of Copenhagen
-
- Sebastiani, Federica (författare)
- Lund University,Lunds universitet,Fysikalisk kemi,Enheten för fysikalisk och teoretisk kemi,Kemiska institutionen,Institutioner vid LTH,Lunds Tekniska Högskola,Physical Chemistry,Physical and theoretical chemistry,Department of Chemistry,Departments at LTH,Faculty of Engineering, LTH,University of Copenhagen
-
- Thakur, Aneesh (författare)
- University of Copenhagen
-
- Foged, Camilla (författare)
- University of Copenhagen
-
visa färre...
-
(creator_code:org_t)
- 2024
- 2024
- Engelska.
-
Ingår i: European Journal of Pharmaceutics and Biopharmaceutics. - 0939-6411. ; 198
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Design of inhalable mRNA therapeutics is promising because local administration in the respiratory tract is minimally invasive and induces a local response. However, several challenges related to administration via inhalation and respiratory tract barriers have so far prevented the progress of inhaled mRNA therapeutics. Here, we investigated factors of importance for lipid nanoparticle (LNP)-mediated delivery of mRNA to the respiratory tract. We hypothesized that: (i) the PEG-lipid content is important for providing colloidal stability during aerosolization and for mucosal delivery, (ii) the PEG-lipid content influences the expression of mRNA-encoded protein in the lungs, and (iii) the route of administration (nasal versus pulmonary) affects mRNA delivery in the lungs. In this study, we aimed to optimize the PEG-lipid content for mucosal delivery and to investigate the effect of administration route on the kinetics of protein expression. Our results show that increasing the PEG-lipid content improves the colloidal stability during the aerosolization process, but has a negative impact on the transfection efficiency in vitro. The kinetics of protein expression in vivo is dependent on the route of administration, and we found that pulmonary administration of mRNA-LNPs to mice results in more durable protein expression than nasal administration. These results demonstrate that the design of the delivery system and the route of administration are important for achieving high mRNA transfection efficiency in the respiratory tract.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)
Nyckelord
- Lipid nanoparticle
- mRNA therapeutics
- Mucosal delivery
- Nanomedicine
- Pulmonary/nasal administration
- Vaccine
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Ongun, Melike
-
Lokras, Abhijeet ...
-
Baghel, Saahil
-
Shi, Zhenning
-
Schmidt, Signe T ...
-
Franzyk, Henrik
-
visa fler...
-
Rades, Thomas
-
Sebastiani, Fede ...
-
Thakur, Aneesh
-
Foged, Camilla
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Farmaceutiska ve ...
- Artiklar i publikationen
-
European Journal ...
- Av lärosätet
-
Lunds universitet